PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
Published in
Pharmaceutics, vol. 12, no. 5, 439Publication date
2020Abstract
Keywords
- Chorioallantoic membrane model
- Cannabinoids
- Cannabidiol
- Gynaecological
- Cancer
- Nanomedicines
UNIGE research groups
Citation (ISO format)
FRAGUAS-SÁNCHEZ, Ana I. et al. PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. In: Pharmaceutics, 2020, vol. 12, n° 5, p. 439. doi: 10.3390/pharmaceutics12050439
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:137377
- DOI : 10.3390/pharmaceutics12050439
- PMID : 32397428
